[{"AccountsPayableCurrent_0_Q3_USD":1329.0,"OperatingIncomeLoss_3_Q3_USD":-480812.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"Cash_0_Q3_USD":998571.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":202187.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q3_USD":52500.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3_Q3_USD":122500.0,"PrepaidExpenseCurrent_0_Q3_USD":202187.0,"ProceedsFromIssuanceOfPrivatePlacement_3_Q3_USD":5600000.0,"SharePrice_0_Q3_USD":10.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":26500.0,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":200000.0,"InvestmentIncomeInterest_1_Q3_USD":73393.0,"InvestmentIncomeInterest_3_Q3_USD":194901.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":998571.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":230000000.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":230194901.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":973571.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":4125486.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q3_shares":21989872.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":219898720.0,"OperatingIncomeLoss_1_Q3_USD":-198480.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"DeferredTaxAssetsNet_0_Q3_USD":70000.0,"StockholdersEquity_0_Q3_USD":5000010.0,"AdditionalPaidInCapital_0_Q3_USD":5300118.0,"Assets_0_Q3_USD":231395659.0,"AssetsCurrent_0_Q3_USD":1200758.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1000000.0,"CommonStockSharesOutstanding_0_Q3_shares":5750000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":95980.0,"GeneralAndAdministrativeExpense_3_Q3_USD":208562.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-125087.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-285911.0,"IncomeTaxExpenseBenefit_1_Q3_USD":12573.0,"IncomeTaxExpenseBenefit_3_Q3_USD":12573.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1329.0,"Liabilities_0_Q3_USD":6496929.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":231395659.0,"LiabilitiesCurrent_0_Q3_USD":196929.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":231474514.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-230000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-500943.0,"NetIncomeLoss_1_Q3_USD":-137660.0,"NetIncomeLoss_3_Q3_USD":-298484.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":200000.0,"ProfitLoss_3_Q3_USD":-298484.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-300784.0,"AccruedLiabilitiesCurrent_0_Q3_USD":28000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"Ticker":"TOI","CIK":"1799191","name":"DFP HEALTHCARE ACQUISITIONS CORP.","OfficialName":"The Oncology Institute Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"520068227.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20201113"}]